Punch & Associates Investment Management Inc. Sells 265,651 Shares of Viemed Healthcare, Inc. $VMD

Key Points

• Punch & Associates Investment Management Inc. has reduced its stake in Viemed Healthcare by 31.4%, selling 265,651 shares to hold a total of 580,000 shares valued at approximately $4.22 million.
• Insiders, including Director Nitin Kaushal, have also been selling shares, with the company experiencing a total of 97,922 shares worth about $703,886 sold in the last ninety days.
• Viemed Healthcare reported earnings of $0.08 per share in its latest quarter, meeting analysts' expectations, with revenues of $63.06 million slightly below consensus estimates.

Punch & Associates Investment Management Inc. reduced its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 31.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 580,000 shares of the company's stock after selling 265,651 shares during the quarter. Punch & Associates Investment Management Inc. owned 1.47% of Viemed Healthcare worth $4,222,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. AQR Capital Management LLC bought a new position in shares of Viemed Healthcare during the first quarter worth about $90,000. Apis Capital Advisors LLC grew its holdings in shares of Viemed Healthcare by 8.7% during the first quarter. Apis Capital Advisors LLC now owns 304,000 shares of the company's stock worth $2,213,000 after buying an additional 24,400 shares in the last quarter. Panagora Asset Management Inc. grew its holdings in shares of Viemed Healthcare by 14.2% during the first quarter. Panagora Asset Management Inc. now owns 235,814 shares of the company's stock worth $1,717,000 after buying an additional 29,252 shares in the last quarter. Trexquant Investment LP grew its holdings in shares of Viemed Healthcare by 68.9% during the first quarter. Trexquant Investment LP now owns 98,531 shares of the company's stock worth $717,000 after buying an additional 40,185 shares in the last quarter. Finally, Gabelli Funds LLC grew its holdings in shares of Viemed Healthcare by 64.9% during the first quarter. Gabelli Funds LLC now owns 116,510 shares of the company's stock worth $848,000 after buying an additional 45,837 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the business's stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the transaction, the director owned 126,843 shares of the company's stock, valued at $889,169.43. The trade was a 21.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Jerome Cambre sold 4,880 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total value of $35,721.60. Following the completion of the sale, the vice president directly owned 84,191 shares of the company's stock, valued at approximately $616,278.12. The trade was a 5.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 97,922 shares of company stock worth $703,886 over the last ninety days. 20.00% of the stock is currently owned by corporate insiders.

Viemed Healthcare Stock Up 0.9%

NASDAQ:VMD opened at $6.88 on Friday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.37 and a current ratio of 1.48. The company has a market cap of $266.88 million, a PE ratio of 20.24 and a beta of 1.38. Viemed Healthcare, Inc. has a 52-week low of $5.93 and a 52-week high of $9.81. The stock has a 50-day simple moving average of $6.80 and a 200 day simple moving average of $6.93.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.08. The business had revenue of $63.06 million during the quarter, compared to the consensus estimate of $63.50 million. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.